Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Single-cell spatial landscapes of the lung tumour immune microenvironmentNature (London), 2023-02, Vol.614 (7948), p.548-554 [Peer Reviewed Journal]2023. The Author(s). ;Copyright Nature Publishing Group Feb 16, 2023 ;The Author(s) 2023 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-022-05672-3 ;PMID: 36725934Full text available |
|
2 |
Material Type: Article
|
Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening TrialJournal of thoracic oncology, 2019-10, Vol.14 (10), p.1732-1742 [Peer Reviewed Journal]2019 ;Copyright © 2019 by the International Association for the Study of Lung Cancer ;Published by Elsevier Inc. ;ISSN: 1556-0864 ;EISSN: 1556-1380 ;DOI: 10.1016/j.jtho.2019.05.044 ;PMID: 31260833Full text available |
|
3 |
Material Type: Article
|
The biology and management of non-small cell lung cancerNature (London), 2018-01, Vol.553 (7689), p.446-454 [Peer Reviewed Journal]COPYRIGHT 2018 Nature Publishing Group ;COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group Jan 25, 2018 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature25183 ;PMID: 29364287Full text available |
|
4 |
Material Type: Article
|
EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical OutcomesJournal of clinical oncology, 2019-02, Vol.37 (4), p.278-285 [Peer Reviewed Journal]2018 by American Society of Clinical Oncology 2018 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.18.01585 ;PMID: 30550363Full text available |
|
5 |
Material Type: Article
|
miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cellsPloS one, 2013-03, Vol.8 (3), p.e60317-e60317 [Peer Reviewed Journal]COPYRIGHT 2013 Public Library of Science ;2013 Chen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 Chen et al 2013 Chen et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0060317 ;PMID: 23555954Full text available |
|
6 |
Material Type: Article
|
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancerNature communications, 2015-03, Vol.6 (1), p.6377-6377, Article 6377 [Peer Reviewed Journal]Copyright Nature Publishing Group Mar 2015 ;Copyright © 2015, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/ncomms7377 ;PMID: 25758528Full text available |
|
7 |
Material Type: Article
|
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8 + T cell exhaustionNature communications, 2020-09, Vol.11 (1), p.4520-4520, Article 4520 [Peer Reviewed Journal]The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-020-18298-8 ;PMID: 32908154Full text available |
|
8 |
Material Type: Article
|
Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung CancerThe New England journal of medicine, 2020-10, Vol.383 (18), p.1711-1723 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2027071 ;PMID: 32955177Full text available |
|
9 |
Material Type: Article
|
Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung CancerThe New England journal of medicine, 2019-11, Vol.381 (21), p.2020-2031 [Peer Reviewed Journal]Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1910231 ;PMID: 31562796Full text available |
|
10 |
Material Type: Article
|
Adjuvant chemotherapy for resected early‐stage non‐small cell lung cancerCochrane database of systematic reviews, 2015-03, Vol.2015 (3), p.CD011430-CD011430 [Peer Reviewed Journal]Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;ISSN: 1469-493X ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD011430 ;PMID: 25730344Full text available |
|
11 |
Material Type: Article
|
Trastuzumab Deruxtecan in HER2-Mutant Non–Small-Cell Lung CancerThe New England journal of medicine, 2022-01, Vol.386 (3), p.241-251 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2112431 ;PMID: 34534430Full text available |
|
12 |
Material Type: Article
|
Over-expression of LSD1 promotes proliferation, migration and invasion in non-small cell lung cancerPloS one, 2012-04, Vol.7 (4), p.e35065-e35065 [Peer Reviewed Journal]COPYRIGHT 2012 Public Library of Science ;COPYRIGHT 2012 Public Library of Science ;2012 Lv et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Lv et al. 2012 ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0035065 ;PMID: 22493729Full text available |
|
13 |
Material Type: Article
|
Progress and prospects of early detection in lung cancerOpen biology, 2017-09, Vol.7 (9), p.170070 [Peer Reviewed Journal]2017 The Authors. ;2017 The Authors. 2017 ;ISSN: 2046-2441 ;EISSN: 2046-2441 ;DOI: 10.1098/rsob.170070 ;PMID: 28878044Full text available |
|
14 |
Material Type: Article
|
Antibodies against endogenous retroviruses promote lung cancer immunotherapyNature (London), 2023-04, Vol.616 (7957), p.563-573 [Peer Reviewed Journal]2023. The Author(s). ;Copyright Nature Publishing Group Apr 20, 2023 ;The Author(s) 2023 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-023-05771-9 ;PMID: 37046094Full text available |
|
15 |
Material Type: Article
|
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 studyThe lancet oncology, 2018-01, Vol.19 (1), p.139-148 [Peer Reviewed Journal]2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;COPYRIGHT 2018 Elsevier B.V. ;Copyright Elsevier Limited Jan 1, 2018 ;2018. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(17)30729-5 ;PMID: 29174310Full text available |
|
16 |
Material Type: Article
|
Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trialThe lancet oncology, 2019-12, Vol.20 (12), p.1655-1669 [Peer Reviewed Journal]2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(19)30634-5 ;PMID: 31591063Full text available |
|
17 |
Material Type: Article
|
The evolution of lung cancer and impact of subclonal selection in TRACERxNature (London), 2023-04, Vol.616 (7957), p.525-533 [Peer Reviewed Journal]2023. The Author(s). ;Copyright Nature Publishing Group Apr 20, 2023 ;The Author(s) 2023 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-023-05783-5 ;PMID: 37046096Full text available |
|
18 |
Material Type: Article
|
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary CancersPloS one, 2015-06, Vol.10 (6), p.e0130142-e0130142 [Peer Reviewed Journal]COPYRIGHT 2015 Public Library of Science ;COPYRIGHT 2015 Public Library of Science ;2015 Carbognin et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Carbognin et al 2015 Carbognin et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0130142 ;PMID: 26086854Full text available |
|
19 |
Material Type: Article
|
Crizotinib-induced immunogenic cell death in non-small cell lung cancerNature communications, 2019-04, Vol.10 (1), p.1486-17, Article 1486 [Peer Reviewed Journal]This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;The Author(s) 2019 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-019-09415-3 ;PMID: 30940805Full text available |
|
20 |
Material Type: Article
|
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung CancerThe New England journal of medicine, 2017-11, Vol.377 (20), p.1919-1929 [Peer Reviewed Journal]Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1709937 ;PMID: 28885881Full text available |